- Papers in database
- 3
- Primary author
- 1 paper
- Years active
- 2019 – 2022
Papers (3)
- 2022Safety of Bifidobacterium breve, Bif195, employing a human exercise-induced intestinal permeability model: a randomised, double-blinded, placebo-controlled, parallel group trial.10.3920/BM2021.0173
- 2021Primary authorLacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial.10.3920/BM2021.0065
- 2019Bifidobacterium breve Bif195 Protects Against Small-intestinal Damage Caused by Acetylsalicylic Acid in Healthy Volunteers.10.1053/j.gastro.2019.05.008